MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-HP-10-0002080
Samay Pharma India Private Limited
Samay Pharma India Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.93 Cr
▲ 2% YoY
Net profit · FY 2025
₹4.14 Lakh
Net margin 0.3%
EBITDA · FY 2025
₹2.13 Cr
EBITDA margin 17.9%
Authorised capital
₹1.65 Cr
Registered with MCA
Paid-up capital
₹1.65 Cr
Issued & subscribed
Open charges
₹17.66 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
1
Provident fund records
About Samay Pharma India Private Limited
Data last updated:
Samay Pharma India Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2020PTC374387. Its GSTIN is 07ABFCS0708Q1ZZ (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1.65 Cr and a paid-up capital of ₹1.65 Cr. It is led by directors Gaurav Jain and Amit Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No. 122 1st Floor Blk – Ru Pitampura Opposite Power House, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.93 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹4.14 Lakh (net margin 0.3%) and EBITDA of ₹2.13 Cr (EBITDA margin 17.9%). Revenue has grown at a compounded annual rate (CAGR) of 96% over three years.
The company has about 1 employee on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹17.66 Cr on record. Court records list 23 cases involving the company, including 11 filed by the company and 12 filed against it; 18 cases are pending.
Samay Pharma India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-10-0002080). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239DL2020PTC374387
Registration Number 374387
Incorporation Date 10 December 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-10-0002080
Recognitions & Rankings of Samay Pharma India
Contact details
Samay Pharma India Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 122 1st Floor Blk – Ru Pitampura Opposite Power House, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Samay Pharma India Private Limited, buy the company report.
Comprehensive company report
Samay Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Samay Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Samay Pharma India Private Limited, buy the company report.
Financials of Samay Pharma India Private Limited
FY 2024 filings availableSamay Pharma India Private Limited reported revenue of ₹11.93 Cr (up 2% YoY) for FY 2025.
Revenue · FY 2025
₹11.93 Cr ▲ 2%
Net profit · FY 2025
₹4.14 Lakh margin 0.3%
EBITDA · FY 2025
₹2.13 Cr margin 17.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 96%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 50%
Revenue has grown at a compounded annual rate (CAGR) of 96% over three years, including 2% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.9% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Samay Pharma India Private Limited, buy the company report.
Board of directors of Samay Pharma India Private Limited
Samay Pharma India has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Jain | Director | 10 Dec 2020 | 5 Years 10 Months | Current |
| Amit Gupta | Additional Director | 25 Aug 2025 | 1 Years 1 Months | Current |
Peer comparison
Samay Pharma India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dallas Drugs Private Limited | ₹12.01 Cr (FY 2025) | 138.0% | Chandigarh, India | |||
| T'walker's Pharmaceuticals Private Limited | ₹12 Cr (FY 2024) | 21.0% | Pune, Maharashtra, India | |||
| Samay Pharma India Private Limitedthis company | ₹11.93 Cr (FY 2025) | ₹4.14 Lakh | 0.3% | 2.0% | 1 | Delhi, India |
| Ridge Formulations Private Limited | ₹11.89 Cr (FY 2025) | -5.0% | Solan, Himachal Pradesh, India | |||
| Mars Remedies Private Limited | ₹11.89 Cr (FY 2025) | 10.0% | Waghodia, Gujarat, India |
To see the full peer comparison of Samay Pharma India Private Limited, buy the company report.
Auditor
Samay Pharma India Private Limited is audited by SUMIT AGGARWAL & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUMIT AGGARWAL & ASSOCIATES | FY 2022 | 022474N |
Shareholding
The shareholding of Samay Pharma India Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Samay Pharma India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹17.66 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Feb 2024 | 100878146 | Hdfc Bank Limited | ₹10.7 Cr | Open | |
| 28 Apr 2023 | 100728259 | Others | ₹93.5 Lakh | Open | |
| 14 Dec 2021 | 100520608 | Others | ₹6.02 Cr | Open |
To see the full charge records of Samay Pharma India Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Samay Pharma India Private Limited has 23 court cases on record: 11 filed by Samay Pharma India, 12 filed against it. 18 cases are pending and 5 are disposed.
Total cases
23
Filed by the company
11
Filed against the company
12
Pending
18
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 12 | 18 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (SUMMARY CIVIL SUIT) | Filed against the company by Hufort Healthcare Pvt Ltd Through Punit Kasat. | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against Ms Synoscot Biotech Pvt Ltd | Pending |
| District court, Agra, Uttar Pradesh | Criminal case | Filed against the company by Radha Shok Farm Pvt Ltd. | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by an individual | Pending |
To see the full case history of Samay Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Samay Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Samay Pharma India Private Limited has a workforce of 1 employees on its EPFO records as of Mar 28, 2024, across 2 active EPFO establishments.
Employee count
1
Active EPFO establishments
2
GST
Samay Pharma India has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABFCS0708Q1ZZ | Delhi | Active | 22 Feb 2021 |
| 02ABFCS0708Q1Z9 | Himachal Pradesh | Active | 08 Jun 2021 |
To see the full GST registrations and return filing status of Samay Pharma India Private Limited, buy the company report.
Recent activity
Samay Pharma India Private Limited has 5 board changes on record since 2020: 3 appointments and 2 cessations. The latest: Amit Gupta was appointed as Additional Director on 25 Aug 2025.
Appointed
Amit Gupta was appointed as Additional Director.
AGM
Samay Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 10.70 Cr registered on 17 Feb 2024 with Charge ID 100878146 was modified on 03 Apr 2024.
Filing
Samay Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.70 Cr with Charge ID 100878146 was registered on 17 Feb 2024.
Charges
A charge with Others amounted to Rs. 0.94 Cr with Charge ID 100728259 was registered on 28 Apr 2023.
Appointed
Priya Aggarwal was appointed as Director.
Ceased
Rahi Jain ceased to be Director.
Charges
A charge with Others of Rs. 6.02 Cr registered on 14 Dec 2021 with Charge ID 100520608 was modified on 14 Jul 2022.
Charges
A charge with Others amounted to Rs. 6.02 Cr with Charge ID 100520608 was registered on 14 Dec 2021.
Ceased
Amit Gupta ceased to be Director.
Appointed
Gaurav Jain was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Samay Pharma India is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 December 2020 (6+ years old) and is registered under CIN U24239DL2020PTC374387.
Samay Pharma India has 2 current directors:
- Gaurav Jain - Director
- Amit Gupta - Additional Director
The latest financial statements of Samay Pharma India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Samay Pharma India is 07ABFCS0708Q1ZZ, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02ABFCS0708Q1Z9 (Himachal Pradesh).
The CIN (Corporate Identification Number) of Samay Pharma India is U24239DL2020PTC374387. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Samay Pharma India has 23 court cases on record: 11 filed by the company and 12 filed against it. 18 are pending. Most are in the district courts.
Samay Pharma India was incorporated on 10 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Samay Pharma India by revenue are Dallas Drugs Private Limited, T'walker's Pharmaceuticals Private Limited, Ridge Formulations Private Limited, Mars Remedies Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amit Gupta was appointed as Additional Director on 25 Aug 2025. Priya Aggarwal was appointed as Director on 10 Dec 2022. Rahi Jain ceased to be Director on 10 Dec 2022. Samay Pharma India has 5 board changes on record in total.
Yes, Samay Pharma India is registered as a small enterprise under Udyam registration (number: UDYAM-HP-10-0002080).
The registered office of Samay Pharma India is at House No. 122 1st Floor Blk – Ru Pitampura Opposite Power House, Delhi, India – 110034.